Results 141 to 150 of about 5,948 (206)

Treatment of primary adult-onset neurodegenerative cerebellar ataxias. [PDF]

Neurotherapeutics
Ariello LE, Rastall DPW, Rosenthal LS.
europepmc   +1 more source

Ataxin-3 Overexpression via Adeno-associated Viral Vector Injection in the Primate Cerebellum: A Novel Model of Spinocerebellar Ataxia Type 3. [PDF]

Exp Neurobiol
Kim K, Kim A, Won J, Park J, Lim KS, Jeon CY, Min J, Cho JH, Song Y, Koo BS, Bae GS, Jeon E, Jeong KJ, Park SH, Lee HY, Choi WS, Lee DS, Lee Y.   +17 more
europepmc   +1 more source

Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxias. [PDF]

Cell Death Dis
Nóbrega C, Marcelo A, Rajado AT, Conceição A, Estevam B, Matos CA, Brito DV, Afonso IT, Codêsso JM, Koppenol R, Costa RG, Afonso-Reis R, Paulino R, Moreira-Gomes T.   +13 more
europepmc   +1 more source

The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort. [PDF]

CNS Drugs
Silva P, Costa MA, Gaspar L, Durães J, Cunha I, Ribeiro JA, Januário C, Oliveiros B, Hübener-Schmid J, Faber J, Raposo M, Lima M, Garcia-Moreno H, Giunti P, Beichert L, Schöls L, van de Warrenburg BP, de Vries J, Thieme A, Reetz K, Jacobi H, Infante J, Klockgether T, ESMI Study Group, de Almeida LP, Santana MM.   +25 more
europepmc   +1 more source

Role of Repeat Tract Structure and the rs7158733 SNP in Spinocerebellar Ataxia 3. [PDF]

Int J Mol Sci
Nethisinghe S, Garcia-Moreno H, Alwan J, Labrum R, Giunti P.   +4 more
europepmc   +1 more source

Dysphagia linked to clinical phenotype and disease progression in spinocerebellar ataxia type 3. [PDF]

Eur J Med Res
Chen CP, Cui ML, Lin W, Huang ZY, Ye BN, Cai B, Gan SR.   +6 more
europepmc   +1 more source

Deep Brain Stimulation for Cerebellar Ataxia: A Systematic Review on Indications, Targets and Outcomes. [PDF]

Cerebellum
Mantovani G, Antenucci P, Collautti E, Gozzi A, Sensi M, Cavallo MA, Scerrati A.   +6 more
europepmc   +1 more source

The Status and Future Directions of Treatments for Polyglutamine Spinocerebellar Ataxia: A Bibliometric and Visual Analysis. [PDF]

Curr Neuropharmacol
Ding S, Peng L, Chen Z, Dong M, Tang C, Gong Y, He L, Wu Q, Qiu R, Jiang H.   +9 more
europepmc   +1 more source

Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3. [PDF]

BMC Neurol
Liu C, Wang X, Xu C, Liu X, Ke L, Li Y, Zhang H, Tan J, Tan S, Zhang Z, Cheng L, Ren Y, Shi L.   +12 more
europepmc   +1 more source

Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review. [PDF]

Int J Mol Sci
Bernardi E, López-Lombardía Ó, Olmedo-Saura G, Pagonabarraga J, Kulisevsky J, Pérez-Pérez J.   +5 more
europepmc   +1 more source